Cargando…

Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine

Tumour cell metabolism is very different from normal cell metabolism; cancer cells re-programme the metabolic pathways that occur in normal cells in such a manner that it optimizes their proliferation, growth and survival. Although this metabolic re-programming obviously operates to the advantage of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhutia, Yangzom D., Babu, Ellappan, Ganapathy, Vadivel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2016
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888454/ https://www.ncbi.nlm.nih.gov/pubmed/27234586 http://dx.doi.org/10.1042/BCJ20160068

Ejemplares similares

RETRACTED ARTICLE: Identification of a novel Na(+)-coupled Fe(3+)-citrate transport system, distinct from mammalian INDY, for uptake of citrate in mammalian cells
por: Ogura, Jiro, et al.
Publicado: (2018)

Retraction Note: Identification of a novel Na(+)-coupled Fe(3+)-citrate transport system, distinct from mammalian INDY, for uptake of citrate in mammalian cells
por: Ogura, Jiro, et al.
Publicado: (2018)

Cell-Surface and Nuclear Receptors in the Colon as Targets for Bacterial Metabolites and Its Relevance to Colon Health
por: Sivaprakasam, Sathish, et al.
Publicado: (2017)

SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
por: Sniegowski, Tyler, et al.
Publicado: (2021)

Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6)
por: Bhutia, Yangzom D., et al.
Publicado: (2022)

PEPT1 is essential for the growth of pancreatic cancer cells: a viable drug target
por: Schniers, Bradley K., et al.
Publicado: (2021)

Consequences of NaCT/SLC13A5/mINDY deficiency: good versus evil, separated only by the blood–brain barrier
por: Kopel, Jonathan J., et al.
Publicado: (2021)

Pharmacologic inducers of the uric acid exporter ABCG2 as potential drugs for treatment of gouty arthritis
por: Ristic, Bojana, et al.
Publicado: (2020)

Transporter-Targeted Nano-Sized Vehicles for Enhanced and Site-Specific Drug Delivery
por: Kou, Longfa, et al.
Publicado: (2020)

Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues
por: Mathew, Marilyn, et al.
Publicado: (2023)

SLC6A14, a Na(+)/Cl(−)-coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling
por: Sikder, Mohd O. F., et al.
Publicado: (2020)

Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
por: Kou, Longfa, et al.
Publicado: (2018)

Plasma Membrane Na(+)-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy
por: Bhutia, Yangzom D., et al.
Publicado: (2017)

Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer
por: Bhutia, Yangzom D., et al.
Publicado: (2020)

Binding of Citrate-Fe(3+) to Plastic Culture Dishes, an Artefact Useful as a Simple Technique to Screen for New Iron Chelators
por: Ogura, Jiro, et al.
Publicado: (2022)

Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer
por: Wang, Zhongjie, et al.
Publicado: (2023)

The pathologist is not a lonely sailor on the sea
por: Mello-Thoms, Claudia
Publicado: (2011)

Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems.
por: Silvestrini, B., et al.
Publicado: (1983)

α-Methyl-l-tryptophan as a weight-loss agent in multiple models of obesity in mice
por: Sivaprakasam, Sathish, et al.
Publicado: (2021)

Sigma Receptors: Novel Regulators of Iron/Heme Homeostasis and Ferroptosis
por: Nguyen, Nhi T., et al.
Publicado: (2023)

Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
por: Cheng, Gang, et al.
Publicado: (2019)

Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases
por: Chen, Chen, et al.
Publicado: (2022)

Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer
por: Schniers, Bradley K., et al.
Publicado: (2022)

Potent Inhibition of Macropinocytosis by Niclosamide in Cancer Cells: A Novel Mechanism for the Anticancer Efficacy for the Antihelminthic
por: Sennoune, Souad R., et al.
Publicado: (2023)

Ru(III) Complexes with Lonidamine-Modified Ligands
por: Shutkov, Ilya A., et al.
Publicado: (2021)

A Proton-Coupled Transport System for β-Hydroxy-β-Methylbutyrate (HMB) in Blood–Brain Barrier Endothelial Cell Line hCMEC/D3
por: Higuchi, Kei, et al.
Publicado: (2021)

Phase II study of lonidamine in metastatic breast cancer.
por: Pronzato, P., et al.
Publicado: (1989)

Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate
por: Babu, Ellappan, et al.
Publicado: (2011)

Expression and function of SLC38A5, an amino acid-coupled Na(+)/H(+) exchanger, in triple-negative breast cancer and its relevance to macropinocytosis
por: Ramachandran, Sabarish, et al.
Publicado: (2021)

Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin
por: Nath, Kavindra, et al.
Publicado: (2018)

Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.
por: De Cesare, M., et al.
Publicado: (1998)

Feeling fearful and lonely are indicative experiences of emotional distress for people with dementia
por: Gruber, Rita, et al.
Publicado: (2021)

Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
por: Guo, Lili, et al.
Publicado: (2016)

Inhibition of the recovery from potentially lethal damage by lonidamine.
por: Hahn, G. M., et al.
Publicado: (1984)

The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment
por: Huang, Yaxin, et al.
Publicado: (2020)

Amino acid transporter SLC38A5 is a tumor promoter and a novel therapeutic target for pancreatic cancer
por: Sniegowski, Tyler, et al.
Publicado: (2023)

Effect of lonidamine derivatives on the inhibition of transformed cell area expansion
por: Aoyama, Megumi, et al.
Publicado: (2023)

Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
por: Cervantes-Madrid, Diana, et al.
Publicado: (2015)

Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line.
por: Citro, G., et al.
Publicado: (1991)

Lonely
Publicado: (1888)

Cannot write session to /tmp/vufind_sessions/sess_8minlgihj82cs2bo552kvgctke